Clinical Trial Detail

NCT ID NCT02307149
Title Study of Intratumoral CAVATAK (Coxsackievirus A21) and Ipilimumab in Patients With Advanced Melanoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Viralytics
Indications

melanoma

Therapies

Coxsackievirus A21

Ipilimumab

Age Groups: adult

No variant requirements are available.